Agios Pharmaceuticals | LinkedIn (original) (raw)

Pharmaceutical Manufacturing

Cambridge, MA 80,474 followers

Where science meets heart. Passionately committed to transforming the lives of people with genetically defined diseases.

About us

Agios is a biopharmaceutical company that is fueled by connections. We are passionately committed to applying our leadership in the field of cellular metabolism to create life-changing therapies for people living with rare diseases. The bonds we build with patient communities, healthcare professionals, partners and colleagues help elevate our thinking and propel our science to new heights. These connections, combined with our cellular metabolism expertise, have fueled the development and approval of our first-in-class pyruvate kinase (PK) activator, as well as other investigational therapies. We’re a company that cares about our work, each other, and the people who are counting on us the most. We’re inspired to think big and welcome the different perspectives and backgrounds needed to deliver extraordinary results.

Industry

Pharmaceutical Manufacturing

Company size

201-500 employees

Headquarters

Cambridge, MA

Type

Public Company

Founded

2008

Specialties

Biopharmaceuticals, Rare Genetic Diseases, Cellular Metabolism, and Hemolytic Anemias

Locations

Employees at Agios Pharmaceuticals

Updates

Join now to see what you are missing

Join now

Similar pages

Browse jobs

Stock

AGIO

November 18, 2024

NASDAQ

20 minutes delay

Open

53.67

Low

52.35

High

53.815

Data from Refinitiv

See more info on Bing

Funding